Recent Articles
Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL)
Recent price shocks in biotech stocks is a good example of the risks investors may be exposed to as healthcare continues to become more complicated.
Best Stocks Update: XLF Has Room to Grow
Our Best Stocks for 2014 pick is the Financial SPDR (XLF), up over 2% year-to-date. Financials are performing well, and XLF should head higher in 2014.
Trade of the Day: Lorillard (LO)
Projected to grow 5-fold to by 2017 , the U.S. market for e cigarette brands is important but exposure to the international market is even more critical.
Stop Stressing Out About JPMorgan and Buy Now
JPMorgan Chase (JPM) should pass the Fed's evaluation with flying colors and extra capital.
Actavis Prescribes Profits via M&A and Generic Drugs
This specialty pharmaceutical company is consolidating its way into becoming a post-Affordable Care Act powerhouse.
Buy Yamana Gold as the Sector’s Glitter Returns
This low-cost producer is completing an inverted head-and-shoulders reversal pattern.
Will Markets Recover From the Shocks?
There are market issues on the horizon that could cascade into major problems. Let's take a look at them and decide how to respond
How Are Valuations Following Earnings Season?
Think about valuation measures in these 2 charts like p/e and the CAPE ratios as a guide to when to accumulate, or pare down, stock holdings.
Trade of the Day: Boeing (BA)
We think that Boeing stock price is going to break up through the $132 level and move back toward the highs it reached in mid-November and mid-January.
Trade of the Day: United States Natural Gas Fund (UNG)
UNG suffers from structural problems that make its long-term losses much more severe than natural gas futures themselves.
Join InvestorPlace Digest — FREE!
Get the best free advice from the world-class analysts at InvestorPlace... delivered straight to your inbox.
